Cargando…
Efficacy and safety of tofacitinib in patients with polymyalgia rheumatica: a phase 2 study
Autores principales: | Zhang, Le, Li, Jun, Yin, Hanlin, Chen, Dandan, Li, Yuan, Gu, Liyang, Fu, Yakai, Chen, Jie, Chen, Zhiwei, Yang, Shaoying, Ye, Shuang, Li, Ting, Lu, Liangjing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10176389/ https://www.ncbi.nlm.nih.gov/pubmed/36604153 http://dx.doi.org/10.1136/ard-2022-223562 |
Ejemplares similares
-
Efficacy and Safety of Tofacitinib in Patients with Polymyalgia Rheumatica (EAST PMR): An open-label randomized controlled trial
por: Ma, Xinlei, et al.
Publicado: (2023) -
Polymyalgia Rheumatica
por: Dixon, A. St J.
Publicado: (1969) -
Polymyalgia rheumatica
por: Rosenberg, Hans, et al.
Publicado: (2021) -
An update on polymyalgia rheumatica
por: Lundberg, Ingrid E., et al.
Publicado: (2022) -
Is Tocilizumab Effective and Safe in Polymyalgia Rheumatica and Giant-Cell Arteritis With Polymyalgia Rheumatica?
por: Farinango, Michelle, et al.
Publicado: (2022)